Two possibly related cases of Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.
This paper describes two possibly related cases of hospital-acquired Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD). To our knowledge these are the first reported cases of CAPD peritonitis with possible cross-contamination by such a microorganism. Investigations for mycobacteria should be performed in all cases of culture-negative peritonitis, especially those which do not respond to the usual antimicrobial therapy.
Soriano
F
F
Department of Clinical Microbiology, Fundación Jimenez Dîaz, Madrid, Spain.
Rodriguez-Tudela
J L
JL
Gómez-Garcés
J L
JL
Velo
M
M
D000328:Adult; D000583:Amikacin / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000209:etiology*; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009164:Mycobacterium Infections / Q000209:etiology*; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000209:etiology*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology*
D000583:Amikacin; D004318:Doxycycline